In vivo versus in vitro individual radiosensitivity analysed in healthy donors and in prostate cancer patients with and without severe side effects after radiotherapy

International Journal of Radiation Biology

Volumn 88, Issue 5, 2012, Pages 405-413

  Brzozowska, Kinga ^a   Pinkawa, Michael ^b   Eble, Michael J ^b   Müller, Wolfgang Ullrich ^c   Wojcik, Andrzej ^d,e   Kriehuber, Ralf ^a   Schmitz, Sabine ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

cancer susceptibility; chromatid aberrations; DNA damage; Individual radiosensitivity; predictive assays; prostate cancer

Indexed keywords

DOUBLE STRANDED DNA; HISTONE H2AX; LIPOCORTIN 5;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CHROMATID ABERRATION; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GAMMA RADIATION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY;

AGED; AGED, 80 AND OVER; APOPTOSIS; CHROMATIDS; CHROMOSOME ABERRATIONS; G2 PHASE; HEALTH; HISTONES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL;

EID: 84860593023     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2012.666002     Document Type: Article

References (46)

1. Andreassen CN, Alsner J, Overgaard J. 2002. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiotherapy and Oncology 64:131-140.
2. Banath JP, MacPhail SH, Olive PL. 2004. Radiation sensitivity, H2AX phospohorylation and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Research 640: 7144-7149.
3. Barber JBP, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D. 2000. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiotherapy and Oncology 55:179-186.
4. Baria K, Warren C, Roberts SA, West CM, Scott D. 2001. Chromosomal radiosensitivity as a marker of predisposition to common cancers? British Journal of Cancer 84:892-896.
5. Begg AC, Russell NS, Knaken H, Lebesque JV. 1993. Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. International Journal of Radiation Biology 64:393-405.
6. Bentzen SM, Overgaard J. 1994. Patient-to-patients variability in the expression of radiation-induced normal tissue injury. Seminars in Radiation Oncology 4:68-80.
7. Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, et al. 2000. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogenesis. Cancer Research 60:1619-1625.
8. Bordon E, Henriquez-Hernandez LA, Lara PC, Pinar B, Rodriquez-Gallego C, Lloret M. 2011. Role of CD4 and CD8 T-lymphocytes, B-lymphocytes and Natural Killer cells in the prediction of radiation-induced late toxicity in cervical cancer patients. International Journal of Radiation Biology 87:424-431.
9. Bordon E, Hernandez LAH, Lara P, Pinar B, Fontes F, Gallego CR, Lloret M. 2009. Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBL). Radiation Oncology 4:1-7.
10. Borgmann K, Raabe A, Reuther S, Szymczak S, Schlomm T, Isbarn H, Gomolka M, Busjahn A, Bonin M, Ziegler A, Dikomey E. 2010. The potential role of G2- but not of G0-radiosensitivity for predisposition of prostate cancer. Radiotherapy and Oncology 96:19-24.
11. Borgmann K, Hoeller U, Nowack S, Bernhard M, R ö per B, Brackrock S, Petersen C, Szymczak S, Ziegler A, Feyer P, Alberti W, Dikomey E. 2008. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reactions after radiotherapy. International Journal of Radiation Oncology Biology Physics 71:256-264.
12. Borgmann K, Haeberle D, Doerk T, Busjahn A, Stephan G, Dikomey E. 2007. Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes. Radiotherapy and Oncology 83:196-202.
13. Bourguignon MH, Gisone PA, Perez MR, Michelin S, Dubner D, Di GM, Carosella ED. 2005. Genetic and epigenetic features in radiation sensitività . Part II: Implications for clinical practice and radiation protection. European Journal of Nuclear Medicine and Molecular Imaging 32:351-368.
14. Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, Maier A, Li L, Schindler D, Ozsahin H, Ozsahin M. 2001. Sources of variation in patient response to radiation treatment. International Journal of Radiation Oncology, Biology, Physics 49:547-554.
15. Crompton NE, Miralbell R, Rutz HP, Ersoy F, Sanal O, Wellmann D, Bieri S, Coucke PA, Emery GC, Shi YQ, Blattmann H, Ozsahin M. 1999. Altered apoptotic profi les in irradiated patients with increased toxicity. International Journal of Radiation Oncology Biology Physics 45:707-714.
16. De Ruyck K, Van Eijkeren M, Claes K, Morthier R, De Paepe A, Vral A, et al. 2005. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3 and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. International Journal of Radiation Oncology, Biology, Physics 62:1140-1149.
17. Dewey WC, Ling CC, Meyn RE. 1995. Radiation-induced apoptosis0: Relevance to radiotherapy. International Journal of Radiation Oncology, Biology, Physics 33:781-796.
18. Docherty Z, Georgiou A, Kesterton I, Rose S, Camplejohn R, Ball J, Barwell J, Gilchrist R, Pangon L, Berg J, Hodgson S. 2007. Is chromosome radiosensitivity and apoptotic response to irradiation correlated with cancer susceptibility? International Journal of Radiation Biology 83:1-12.
19. Edwards AA, Lloyd DC, Purrott RJ. 1979. Radiation-induced chromosome aberrations and the Poisson distribution. Radiation and Environmental Biophysics 16:89-100.
20. Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E. 2003. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiotherapy and Oncology 69:137-144.
21. Howe O, O'Malley K, Lavin M, Gardner RA, Seymour C, Lyng F, Mulvin D, Quinlan DM, Mothersill C. 2005. Cell death mechanisms associated with G2 radiosensitivity in patients with prostate cancer and benign prostatic hyperplasia. Radiation Research 164:627-634.
22. Ivashkevich AN, Martin OA, Smith AJ, Redon CE, Bonner WM, Martin RF, Lobachevsky PN. 2011. γ-H2AX foci as ameasure of DNA damage: A computational approach to automatic analysis. Mutation Research 711:49-60.
23. Joubert A, Zimmerman KM, Bencokova Z, Gastaldo J, Chavaudra N, Favaudon V, Arlett CF, Foray N. 2008. DNA double-strand break repair defects in syndromes associated with acute radiation response0: At least two different assays to predict intrinsic radiosensitivity? International Journal of Radiation Biology 84:107-125.
24. Lee TK, Allison RR, O'Brien KF, et al. 2003. Lymphocytes radiosensitivity correlated with pelvic radiotherapy morbidity. International Journal of Radiation Oncology, Biology, Physics 57:222-229.
25. Lisowska H, Lankoff A, Wieczorek A, Florek A, Kuszewski T, Gozd S, Wojcik A. 2006. Enhanced chromosomal radiosensitivity in peripheral blood lymphocytes of larynx cancer patients. International Journal of Radiation Oncology, Biology, Physics 66:1245-1252.
26. L öbrich M, Rief N, K ühne M, Heckmann M, Fleckenstein J, R übe C, Uder M. 2005. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proceedings of the National Academy of Sciences of the USA 102:8984-8989.
27. MacKay RI, Niemierko A, Goitein M, Hendry JH. 1998. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiotherapy and Oncology 46:215-219.
28. Mossman LK. 1997. Radiation protection of radiosensitive populations. Health Physics 72:519-523.
29. Muanza TM, Albert PS, Smith S, Dodette D, Crouse NS, Cooley-Zgela T, Sciuto L, Camphausen K, Coleman N, M é nard C. 2005. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy. International Journal of Radiation Oncology, Biology, Physics 62:1316-1321.
30. Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, Sozzi WJ, Zouhair A, Mirimanoff RO, Azria D. 2005. CD4 and CD8 T-lymphocytes apoptosis can predict radiation-induced late toxicity: A prospective study in 399 patients. Clinical Cancer Research 11:7426-7433.
31. Papworth R, Slevin N, Roberts SA, Scott D. 2001. Sensitivity to radiationinduced chromosome damage may be a genetic predisposition in young head and neck cancer patients. British Journal of Cancer 84:776-782.
32. Pinkawa M, Piroth MD, Holy R, Fischedick K, Schaar S, Sz é kely-Orbá n D, Eble MJ. 2010. Consequential late Effects after radiotherapy for prostate cancer - A prospective longitudinal quality of life study. Radiation Oncology 5:27.
33. Roberts SA, Spreadborough AR, Bulman B, Barber JBP, Evans DGR, Scott D. 1999. Heritability of cellular radiosensitivity: A marker of low penetrance predisposition genes in breast cancer? American Journal of Human Genetics 65:784-794.
34. Rothkamm K, L ö brich M. 2003. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proceedings of the National Academy of Sciences of the USA 100:5057-5062.
35. Rudat V, Dietz A, Conradt C, Weber KJ, Flentje M. 1997. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiotherapy and Oncology 43:181-188.
36. Russell NS, Begg AC. 2002. Predictive assays for normal tissue damage. Radiotherapy and Oncology 64:125-129.
37. Sanford KK, Parshad R, Gantt RE, Tarone RE, Jones GM, Price FM. 1989. Factors aff ecting and signifi cance of G2 chromatin radiosensitivity and predisposition to cancer. International Journal of Radiation Biology 55:963-968.
38. Scott D, Barber JBP, Spreadborough AR, Burrill W, Roberts SA. 1999. Increased chromosomal radiosensitivity in breast cancer patients0: A comparison of two assays. International Journal of Radiation Biology 75:1-10.
39. Scott D, Spreadborough A, Levine E, Roberts SA. 1994. Genetic predisposition in breast cancer. The Lancet 344:1444.
40. Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA. 1975. Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature 258:427-429.
41. Turesson I, Nyman J, Holmberg E, Oden A. 1996. Prognostic factors for acute and late skin reactions in radiotherapy patients. International Journal of Radiation Oncology, Biology, Physics 36:1065-1075.
42. Volz-Sideropoulou E, Pinkawa M, Fischedick K, Jakse G, Gauggel S, Eble MJ. 2008. Factor analysis of the Expanded Prostate Cancer Index Composite (EPIC) in a patient group after primary (external beam radiotherapy and permanent iodine-125 brachyterapy) and postoperative radiotherapy for prostate cancer. Current Urology 2:122-129.
43. Wang WD, Chen ZT, Li DZ, Cao ZH, Sun SL, Pu P, Chen XP. 2005. Correlation between DNA repair capacity in lymphocytes and acute side Effects to skin during radiotherapy in nasopharyngeal cancer patients. Clinical Cancer Research 11:5140-5145.
44. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. 2000. Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899-905.
45. Widel M, Kolosza Z, Jedruś S, Lukaszczyk B, Raczek-Zwierzycka K, Swierniak A. 2001. Micronucleus assay in vivo provides signifi cant prognostic information in human cervical carcinoma; the updated analysis. International Journal of Radiation Biology 77:631-636.
46. Widel M, Jedrus S, Lukaszczyk B, Raczek-Zwierzycka K, Swierniak A. 2003. Radiation-induced micronucleus frequency in peripheral blood lymphocytes is correlated with normal tissue damage in patients with cervical carcinoma undergoing radiotherapy. Radiation Research 159:713-721.